No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is the most common hepatic disorder worldwide, reaching prevalence up to 90 % in obese patients with type 2 diabetes (T2D), and representing an independent risk factor for cardiovascular mortality. Furthermore, the coexistence of T2D and NAFLD le...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:BMC Med
Autores principales: Barchetta, Ilaria, Del Ben, Maria, Angelico, Francesco, Di Martino, Michele, Fraioli, Antonio, La Torre, Giuseppe, Saulle, Rosella, Perri, Ludovica, Morini, Sergio, Tiberti, Claudio, Bertoccini, Laura, Cimini, Flavia Agata, Panimolle, Francesca, Catalano, Carlo, Baroni, Marco Giorgio, Cavallo, Maria Gisella
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4926287/
https://ncbi.nlm.nih.gov/pubmed/27353492
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-016-0638-y
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares